Skip to main content

Client News

Affluent Medical: Pre-submission dossier for the 510(k) of medical device Kalios filed with FDA for review

15th January 2024

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

11th January 2024

Mainz Biomed Provides Year-End Corporate Review 2023

9th January 2024

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS® for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients

9th January 2024

InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904

4th January 2024

Abivax 2024 Financial Communication Calendar

4th January 2024

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

4th January 2024

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

29th December 2023

CARBIOS publishes its second sustainability report and confirms its ambitions to accelerate the circular economy for plastic

21st December 2023

invIOs to attend JP Morgan Week in San Francisco in January

21st December 2023